Open AccessEffect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial
Author(s) -
Eun-Ji Song,
Kyungsun Han,
Tae-Joong Lim,
Sanghyun Lim,
Myung Jun Chung,
Myung Hee Nam,
Hojun Kim,
Young-Do Nam
Publication year - 2020
Publication title -
the epma journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.177
H-Index - 34
eISSN - 1878-5085
pISSN - 1878-5077
DOI - 10.1007/s13167-020-00198-y
Subject(s) - prevotella , bacteroides , gut flora , placebo , medicine , obesity , probiotic , waist , endocrinology , gastroenterology , physiology , biology , pathology , immunology , genetics , alternative medicine , bacteria
Prevention and improvement of disease symptoms are important issues, and probiotics are suggested as a good treatment for controlling the obesity. Human gut microbiota has different community structures. Because gut microbial composition is assumed to be linked to probiotic function, this study evaluated the efficacy of probiotics on obesity-related clinical markers according to gut microbial enterotype.